RASD1 and cancer: Overall, the infrequent occurrence of copy number alterations and the absence of recurrent predicted loss-of-function mutations across various cancer types suggest that genetic alterations in RASD1 may not play a significant role in modulating RASD1 expression or activity in the cancers analyzed.